NO20030821L - Gener og proteiner, og deres anvendelse - Google Patents
Gener og proteiner, og deres anvendelseInfo
- Publication number
- NO20030821L NO20030821L NO20030821A NO20030821A NO20030821L NO 20030821 L NO20030821 L NO 20030821L NO 20030821 A NO20030821 A NO 20030821A NO 20030821 A NO20030821 A NO 20030821A NO 20030821 L NO20030821 L NO 20030821L
- Authority
- NO
- Norway
- Prior art keywords
- genes
- proteins
- products
- immunization
- vaccines
- Prior art date
Links
- 108090000623 proteins and genes Proteins 0.000 title abstract 4
- 102000004169 proteins and genes Human genes 0.000 title 1
- 241000588650 Neisseria meningitidis Species 0.000 abstract 1
- 230000003053 immunization Effects 0.000 abstract 1
- 238000002649 immunization Methods 0.000 abstract 1
- 229940075461 other therapeutic product in atc Drugs 0.000 abstract 1
- 239000013076 target substance Substances 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Oncology (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0020952.8A GB0020952D0 (en) | 2000-08-24 | 2000-08-24 | Genes and proteins and their uses |
| PCT/GB2001/003759 WO2002016612A2 (fr) | 2000-08-24 | 2001-08-21 | Gènes et protéines et leurs utilisations |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20030821D0 NO20030821D0 (no) | 2003-02-21 |
| NO20030821L true NO20030821L (no) | 2003-04-15 |
Family
ID=9898283
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20030821A NO20030821L (no) | 2000-08-24 | 2003-02-21 | Gener og proteiner, og deres anvendelse |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20040073000A1 (fr) |
| EP (1) | EP1373511A2 (fr) |
| JP (1) | JP2004507245A (fr) |
| KR (2) | KR20080052693A (fr) |
| CN (1) | CN1545552A (fr) |
| AU (2) | AU2001282299B2 (fr) |
| CA (1) | CA2420261A1 (fr) |
| GB (1) | GB0020952D0 (fr) |
| HU (1) | HUP0300813A3 (fr) |
| NO (1) | NO20030821L (fr) |
| NZ (3) | NZ538864A (fr) |
| RU (1) | RU2313535C2 (fr) |
| WO (1) | WO2002016612A2 (fr) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1706481A2 (fr) * | 2003-12-23 | 2006-10-04 | GlaxoSmithKline Biologicals S.A. | Vaccin |
| US7709001B2 (en) | 2005-04-08 | 2010-05-04 | Wyeth Llc | Multivalent pneumococcal polysaccharide-protein conjugate composition |
| TWI445545B (zh) | 2005-04-08 | 2014-07-21 | Wyeth Corp | 多價肺炎球菌多醣-蛋白質共軛物組合物 |
| US8261648B1 (en) | 2011-10-17 | 2012-09-11 | Sequent Medical Inc. | Braiding mechanism and methods of use |
| CN116326547B (zh) * | 2023-01-06 | 2023-11-10 | 广东省农业科学院植物保护研究所 | 一种针对荔枝蒂蛀虫幼虫室内毒力测定方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU1202200A (en) * | 1998-10-09 | 2000-05-01 | Chiron Corporation | Neisseria genomic sequences and methods of their use |
| WO2000023595A1 (fr) * | 1998-10-22 | 2000-04-27 | The University Of Montana | Proteines omp85 de neisseria gonorrhoeae et de neisseria meningitidis, compositions renfermant lesdites proteines et methodes d'utilisation correspondantes |
| ES2563677T3 (es) * | 1999-05-19 | 2016-03-15 | Glaxosmithkline Biologicals Sa | Composiciones de combinaciones de Neisseria |
| US20050100892A1 (en) * | 2002-07-22 | 2005-05-12 | Shea Terrance P.Jr. | Method of selecting genes for crop improvement |
-
2000
- 2000-08-24 GB GBGB0020952.8A patent/GB0020952D0/en not_active Ceased
-
2001
- 2001-08-21 KR KR1020087012388A patent/KR20080052693A/ko not_active Application Discontinuation
- 2001-08-21 KR KR10-2003-7002608A patent/KR20030045039A/ko not_active Application Discontinuation
- 2001-08-21 EP EP01960908A patent/EP1373511A2/fr not_active Withdrawn
- 2001-08-21 JP JP2002522283A patent/JP2004507245A/ja active Pending
- 2001-08-21 WO PCT/GB2001/003759 patent/WO2002016612A2/fr active IP Right Grant
- 2001-08-21 NZ NZ538864A patent/NZ538864A/en not_active IP Right Cessation
- 2001-08-21 RU RU2003107837/13A patent/RU2313535C2/ru not_active IP Right Cessation
- 2001-08-21 AU AU2001282299A patent/AU2001282299B2/en not_active Ceased
- 2001-08-21 CN CNA01815395XA patent/CN1545552A/zh active Pending
- 2001-08-21 NZ NZ524277A patent/NZ524277A/en unknown
- 2001-08-21 HU HU0300813A patent/HUP0300813A3/hu unknown
- 2001-08-21 NZ NZ548093A patent/NZ548093A/en unknown
- 2001-08-21 US US10/362,327 patent/US20040073000A1/en not_active Abandoned
- 2001-08-21 AU AU8229901A patent/AU8229901A/xx active Pending
- 2001-08-21 CA CA002420261A patent/CA2420261A1/fr not_active Abandoned
-
2003
- 2003-02-21 NO NO20030821A patent/NO20030821L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2420261A1 (fr) | 2002-02-28 |
| KR20080052693A (ko) | 2008-06-11 |
| JP2004507245A (ja) | 2004-03-11 |
| AU8229901A (en) | 2002-03-04 |
| WO2002016612A3 (fr) | 2003-10-09 |
| KR20030045039A (ko) | 2003-06-09 |
| HUP0300813A2 (hu) | 2003-10-28 |
| WO2002016612A2 (fr) | 2002-02-28 |
| GB0020952D0 (en) | 2000-10-11 |
| NZ538864A (en) | 2007-03-30 |
| AU2001282299B2 (en) | 2007-08-02 |
| US20040073000A1 (en) | 2004-04-15 |
| HUP0300813A3 (en) | 2007-10-29 |
| NO20030821D0 (no) | 2003-02-21 |
| EP1373511A2 (fr) | 2004-01-02 |
| NZ548093A (en) | 2007-11-30 |
| RU2313535C2 (ru) | 2007-12-27 |
| NZ524277A (en) | 2005-09-30 |
| CN1545552A (zh) | 2004-11-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1121353T1 (el) | Anti-tnf αντισωματα, συνθεσεις, μεθοδοi και χρησεις | |
| CY1119650T1 (el) | Anti-il-12 αντισωματα, συνθεσεις, μεθοδοι και χρησεις | |
| NO20060128L (no) | Krystallinske tumornekrosesfaktor reseptor 2-polypeptider | |
| CY1106602T1 (el) | Παραγωγα αδαμαντανιου για τη θεραπεια φλεγμονωδων, ανοσολογικων και καρδιαγγειακων ασθενειων | |
| NO20033364D0 (no) | Fremgangsmåte for identifikasjon, isolasjon og produksjon av antigener tilet spesifikt patogen | |
| NO20060808L (no) | Andvendelse av en PAK-inhibitorer for behandling av en leddsykdom | |
| DK117491A (da) | Vaccine imod meningococcussygdomme, deri indgaaende komponenter, disses anvendelse og rekombinanter, som eksprimerer dem | |
| NZ331651A (en) | BSW17 peptide immunogens for vaccination against and treatment of allergy | |
| CY1113020T1 (el) | Εμβολια συνδυασμου για neisseria meningitidis | |
| CY1107841T1 (el) | Φαρμακευτικα σκευασματα τα οποια περιλαμβανουν μυκοφαινολικο οξυ ή μυκοφαινολικο αλας | |
| ATE542829T1 (de) | Impfstoff | |
| EA201301072A1 (ru) | Антитела против il-23p19 и их применение | |
| CY1108085T1 (el) | Υποκατεστημενα παραγωγα 1,3-διφαινυλπροπ-2-εν-1-ονης παρασκευη και χρησης αυτων | |
| Rochereau et al. | Secretory IgA as a vaccine carrier for delivery of HIV antigen to M cells | |
| CY1117746T1 (el) | Αντιγονα αιμοφιλου της γριπης και αντιστοιχα θραυσματα dna | |
| DK1441764T3 (da) | Antigen-Arrays der omfatter RANKL til behandling af knoglesygdom | |
| DE59912185D1 (de) | Verwendung von hsp70 protein | |
| NO20030821L (no) | Gener og proteiner, og deres anvendelse | |
| UA89800C2 (en) | Acylated nonadepsipeptides used as lysobactin derivatives | |
| NO20025329D0 (no) | Virulensgener, proteiner og deres anvendelse | |
| NO20054417L (no) | Fremgangsmate for fremstilling av farmasoytiske preperater i form av fibratholdige tabletter og de derved fremstilte tabletter | |
| SG149001A1 (en) | N-aryl piperidine substituted biphenylcarboxamides as inhibitors of apolipoprotein b | |
| DK0787135T3 (da) | Vandopløslige derivater af epipodophyllotoxin, fremgangsmåde til fremstilling deraf og anvendelse som et lægemiddel til beh | |
| DE60109922D1 (de) | Therapeutische verbindungen gegen eierstockkrebs | |
| NO20023006D0 (no) | Virulens gener, proteiner og deres anvendelse |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |